This approach enables an ongoing dialogue between the regulatory body and drug developers. Expediting the review process ...

Lastly, artificial intelligence (AI) is increasingly used in drug development, with the FDA exploring its potential in enhancing process control and optimizing the pharmaceutical supply chain.

Robert F. Kennedy Jr., President-elect Trump’s nominee for secretary of health and human services, has said one of his mandates from ...

The Digital Health Advisory Committee (DHAC) held its first meeting to offer guidance to the FDA on a slew of questions ...

The FDA has released a draft of new guidance addressing common FAQs about the development of potential CGT treatments.

This course will benefit professionals involved in working with pharmaceutical and Biotech products and management involved in drug development and FDA Regulatory Compliance. Regulatory Compliance ...

I think we should have a golden age of innovation and drug development ... failing to earn the sign-off of the FDA's reviewers during the voluntary process. That has strayed far from the original ...

Any changes Robert F. Kennedy Jr. wants to make will come up against a pharmaceutical industry that pays much of the U.S.

The FDA has scuttled Merus’ plans to win a speedy approval for its solid tumor drug zenocutuzumab ... rather than the typical 10-month process, Merus was scheduled to learn if the FDA would ...

Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will ...